Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis

OBJECTIVES: To investigate if the OMERACT PsA MRI Scoring System (PsAMRIS), including a novel total inflammation score, shows sensitivity to change with an agent (abatacept) known to impact clinical outcomes in PsA. METHODS: We performed a post hoc analysis of a randomized phase IIb study of abatace...

Descripción completa

Detalles Bibliográficos
Autores principales: Østergaard, Mikkel, Bird, Paul, Pachai, Chahin, Du, Shuyan, Wu, Chun, Landis, Jessica, Fuerst, Thomas, Ahmad, Harris A, Connolly, Sean E, Conaghan, Philip G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629349/
https://www.ncbi.nlm.nih.gov/pubmed/35137002
http://dx.doi.org/10.1093/rheumatology/keac073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629349/
https://www.ncbi.nlm.nih.gov/pubmed/35137002
http://dx.doi.org/10.1093/rheumatology/keac073

Ejemplares similares